Dr Ravindran Kanesvaran is a Senior Consultant in the Department of Medical Oncology of the National Cancer Centre Singapore. He is also an Assistant Professor at Duke-NUS Graduate Medical School and clinical senior lecturer at the Yong Loo Lin School of Medicine, National University of Singapore. He is actively involved in graduate medical education and is the Program Director of the Medical Oncology Senior Residency Program. He completed his medical oncology speciality training in the National Cancer Centre Singapore. After completion of that training he followed up with a fellowship in genitourinary oncology (GU) and geriatric oncology in Duke Cancer Institute in North Carolina, USA on a Healthcare Manpower Development Program (HMDP) scholarship awarded by the Ministry of Health Singapore. His research interests include GU oncology and geriatric oncology. He has published in a number of well-known peer reviewed journals including Journal of Clinical Oncology and Lancet Oncology. He is the author of several textbook chapters in Geriatric Oncology.
He has also been awarded a number of awards including the American Society of Clinical Oncology (ASCO GU) Merit Award 2009, American Association for Cancer Research (AACR) scholar-in-training Award 2010 and European Society for Medical Oncology (ESMO) fellowship award 2012. He is currently the Immediate Past President of the Singapore Society of Oncology (SSO) and the Singapore Geriatric Oncology Society. He had been appointed as European Society for Medical Oncology (ESMO) Faculty 2015-2016 in Geriatric Oncology and 2016-2020 in GU Oncology. He was the host and steering committee member of the first ESMO Asia meeting in 2015 and currently the co-chair of the ESMO Leaders Generation Program for Asia. He is on the Board of Governance and the National Representative for Singapore in the International Society of Geriatric Oncology (SIOG). He was awarded National Representative of the Year SIOG 2014 award. He is also the Vice Chairman of the Singapore Cancer Society (SCS).